Vitamin Shoppe Inc (NYSE:VSI) – Analysts at Jefferies Financial Group dropped their Q1 2020 earnings per share estimates for Vitamin Shoppe in a research note issued to investors on Wednesday, November 6th. Jefferies Financial Group analyst S. Wissink now anticipates that the specialty retailer will post earnings of $0.17 per share for the quarter, down from their previous estimate of $0.19. Jefferies Financial Group also issued estimates for Vitamin Shoppe’s Q3 2020 earnings at ($0.01) EPS and FY2020 earnings at $0.31 EPS.

VSI has been the subject of several other research reports. Zacks Investment Research lowered Vitamin Shoppe from a “buy” rating to a “hold” rating in a report on Friday. ValuEngine raised Vitamin Shoppe from a “sell” rating to a “hold” rating in a report on Thursday, August 8th.

Shares of NYSE VSI opened at $6.47 on Friday. Vitamin Shoppe has a 12 month low of $3.32 and a 12 month high of $8.85. The company has a current ratio of 1.18, a quick ratio of 0.23 and a debt-to-equity ratio of 2.37. The firm has a market capitalization of $155.69 million, a price-to-earnings ratio of 24.88 and a beta of 1.59. The business has a 50-day moving average of $6.56 and a 200-day moving average of $5.44.

Vitamin Shoppe (NYSE:VSI) last issued its quarterly earnings data on Thursday, August 8th. The specialty retailer reported $0.20 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.12 by $0.08. Vitamin Shoppe had a positive return on equity of 3.34% and a negative net margin of 0.66%. The company had revenue of $270.88 million during the quarter, compared to analyst estimates of $278.60 million.

Hedge funds and other institutional investors have recently modified their holdings of the company. Invesco Ltd. grew its holdings in shares of Vitamin Shoppe by 78.7% during the second quarter. Invesco Ltd. now owns 1,040,722 shares of the specialty retailer’s stock worth $4,100,000 after purchasing an additional 458,230 shares in the last quarter. VIEX Capital Advisors LLC boosted its stake in Vitamin Shoppe by 1,496.9% in the second quarter. VIEX Capital Advisors LLC now owns 2,198,449 shares of the specialty retailer’s stock worth $8,662,000 after buying an additional 2,060,782 shares in the last quarter. GABELLI & Co INVESTMENT ADVISERS INC. purchased a new stake in Vitamin Shoppe in the third quarter worth approximately $2,318,000. GSA Capital Partners LLP boosted its stake in Vitamin Shoppe by 60.7% in the second quarter. GSA Capital Partners LLP now owns 115,659 shares of the specialty retailer’s stock worth $456,000 after buying an additional 43,691 shares in the last quarter. Finally, BlackRock Inc. boosted its stake in Vitamin Shoppe by 2.0% in the second quarter. BlackRock Inc. now owns 1,660,359 shares of the specialty retailer’s stock worth $6,541,000 after buying an additional 32,267 shares in the last quarter. 92.39% of the stock is owned by institutional investors.

About Vitamin Shoppe

Vitamin Shoppe, Inc, through its subsidiaries, operates as a omni-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates in two segments, Retail and Manufacturing. The company provides custom manufacturing and private labeling services for vitamin, mineral, and supplement products, as well as develops and markets own branded products.

Read More: How analysts view the yield curve

Earnings History and Estimates for Vitamin Shoppe (NYSE:VSI)

Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.